Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use

作者
Kent T. J. Chen,Malathi Anantha,Ada W.Y. Leung,Jayesh A. Kulkarni,Gardenia G. C. Militao,Mohamed Wehbe,Brent W. Sutherland,Pieter R. Cullis,Marcel B. Bally
出处
期刊:Drug Delivery and Translational Research [Springer Science+Business Media]
卷期号:10 (1): 202-215 被引量:42
标识
DOI:10.1007/s13346-019-00674-7
摘要

Quercetin (3,3′,4′,5,7-pentahydroxyflavone) is a naturally derived flavonoid that is commonly found in fruits and vegetables. There is mounting evidence to suggest that quercetin has potential anticancer effects and appears to interact synergistically when used in combination with approved chemotherapeutic agents such as irinotecan and cisplatin. Unfortunately, quercetin has shown limited clinical utility, partly due to low bioavailability related to its poor aqueous solutions (< 10 μg/mL). In this study, liposomal formulations of quercetin were developed by exploiting quercetin’s ability to bind copper. Quercetin powder was added directly to pre-formed copper-containing liposomes (2-distearoyl-sn-glycero-3-phosphocholine (DSPC) and cholesterol (CHOL) (55:45 M ratio)). As a function of time and temperature, the formation of copper-quercetin was measured. Using this methodology, a final quercetin-to-lipid (mol:mol) ratio of 0.2 was achievable and solutions containing quercetin at concentrations of > 5 mg/mL were attained, representing at least a > 100-fold increase in apparent solubility. The resulting formulation was suitable for intravenous dosing with no overt toxicities when administered at doses of 50 mg/kg in mice. Pharmacokinetic studies demonstrated that the copper-quercetin formulations had an AUC 0-24H of 8382.1 μg h/mL when administered to mice at 50 mg/kg. These studies suggested that quercetin (not copper-quercetin) dissociates from the liposomes after administration. The resulting formulation is suitable for further development and also serves as a proof-of-concept for formulating other flavonoids and flavonoid-like compounds. Given that quercetin exhibits an IC 50 of >10 μM when tested against cancer cell lines, we believe that the utility of this novel quercetin formulation for cancer indications will ultimately be as a component of a combination product.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
流觞俊秀完成签到 ,获得积分10
刚刚
负责的紫安完成签到 ,获得积分10
刚刚
刚刚
博士搏斗完成签到 ,获得积分10
1秒前
海燕完成签到 ,获得积分10
1秒前
马格发布了新的文献求助10
2秒前
2秒前
澪617完成签到,获得积分10
2秒前
无极微光的应助被叫我第一名采纳,获得20
2秒前
Xiaoyan完成签到,获得积分10
3秒前
小圆子完成签到,获得积分10
3秒前
alei1203完成签到,获得积分10
3秒前
3秒前
一氧化二氢完成签到,获得积分10
3秒前
帆子完成签到 ,获得积分10
4秒前
zhanga发布了新的文献求助10
4秒前
CodeCraft的应助被独一无二的鱼采纳,获得10
4秒前
鹧鸪完成签到 ,获得积分10
4秒前
孙新雨完成签到,获得积分10
5秒前
LINLIN发布了新的文献求助10
5秒前
zmang完成签到 ,获得积分10
5秒前
arniu2008发布了新的文献求助10
5秒前
芯止谭轩完成签到,获得积分10
5秒前
英俊的铭的应助被zhanga采纳,获得10
5秒前
老头完成签到 ,获得积分10
5秒前
6秒前
。。完成签到,获得积分10
6秒前
wqx完成签到,获得积分10
6秒前
troyqiujing完成签到,获得积分0
7秒前
7秒前
一二三完成签到,获得积分10
7秒前
忧虑的凌雪完成签到,获得积分10
7秒前
传奇3的应助被ericaxixi采纳,获得10
7秒前
hsing完成签到,获得积分10
7秒前
虚室生白完成签到,获得积分10
7秒前
鲸落发布了新的文献求助10
8秒前
syl发布了新的文献求助10
8秒前
勤劳冰安完成签到,获得积分10
8秒前
HowesFeng完成签到,获得积分10
9秒前
123444发布了新的文献求助10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173580
求助须知:如何正确求助?哪些是违规求助? 9565737
关于积分的说明 21782083
捐赠科研通 7767775
什么是DOI,文献DOI怎么找? 3431604
关于科研通互助平台的介绍 2555855
邀请新用户注册赠送积分活动 2476870